Showing results (2841-2850 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|August 22, 2021
Inhibitory effect of a novel thiazolidinedione derivative on hepatitis B virus entryTomohisa Tanaka, Kaori Okuyama-Dobashi, Ryoji Motohashi, et al.Antiviral Research|November 1, 1987
Antiviral effects of dihydroxypropyladenine [RS)-DHPA) and bromovinyldeoxyuridine (BVDU) on plant virusesG De Fazio, M Vicente, E De ClercqAntiviral Research|August 8, 2022
Matrix metalloproteinase 3 restricts viral infection by enhancing host antiviral immunityTingting Feng, Hao Tong, Zhihao Ming, et al.Antiviral Research|April 11, 2020
Type 1 interferons as a potential treatment against COVID-19Erwan Sallard, François-Xavier Lescure, Yazdan Yazdanpanah, et al.Antiviral Research|May 8, 2021
Clinical outcome and the role of antivirals in congenital cytomegalovirus infectionShannon A Ross, David KimberlinAntiviral Research|May 9, 2021
Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphavirusesShih-Chao Lin, Caitlin W Lehman, Allison K Stewart, et al.Antiviral Research|June 25, 2020
Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitroZhanding Cui, Dengliang Li, Yinli Xie, et al.Antiviral Research|May 5, 2015
The hepatitis B virus (HBV) core protein enhances the transcription activation of CRE via the CRE/CREB/CBP pathwayAn Xiang, Fengling Ren, Xiaoying Lei, et al.Antiviral Research|May 5, 2015
Development of a novel cell-based assay to monitor the transactivation activity of the HSV-1 protein ICP0Angela M Fowler, Heather E Shinogle, David J DavidoAntiviral Research|June 6, 2020
A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemiaMin Wu, Cong Wang, Bisheng Shi, et al.Pageof 523